Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061087 · ClinicalTrials.gov registry record · Phase 2
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
A Phase 2 study of ADHD and Opioid-Related Disorders, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT00061087 is a Phase 2 study of ADHD and Opioid-Related Disorders that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 115 participants, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00061087, a Phase 2 study of ADHD and Opioid-Related Disorders, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to treat Adult Attention Deficit Hyperactivity Disorder (ADHD) in methadone patients.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Methylphenidate
- DRUG Bupropion
Study Locations (1)
New York
- Research Foundation for Mental Hygiene, Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 1998-02 |
| Est. Completion | 2004-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00061087
The ClinicalTrials.gov registry entry for NCT00061087 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (39% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with ADHD appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00061087 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00061087 about?
NCT00061087 is a clinical study titled "Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1". The purpose of this study is to treat Adult Attention Deficit Hyperactivity Disorder (ADHD) in methadone patients.
What is the current status of trial NCT00061087?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 115 participants. The study started on 1998-02. Estimated completion is 2004-10.
What conditions does trial NCT00061087 study?
This clinical trial studies the following conditions: ADHD, Opioid-Related Disorders, Cocaine Dependence.
What interventions are being tested in trial NCT00061087?
The interventions under investigation include: Placebo (OTHER), Methylphenidate (DRUG), Bupropion (DRUG).
Who is sponsoring clinical trial NCT00061087?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00061087 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD
COMPLETED · Phase 2
-
A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
COMPLETED · Phase 2
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.